Efficacy and safety of lamotrigine in refractory epilepsy of children

Eastern Journal of Medicine

Volumn 13, Issue 1-2, 2008, Pages 7-12

  Fallah, Razieh ^a   Islami, Zia ^a   Tavakoli, Nasim ^a  

^a Shaheed Sadoughi Medical Sciences and Health Services University   (Iran)

Author keywords

Add on therapy; Children; Lamotrigine; Refractory epilepsy

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; LAMOTRIGINE; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADD ON THERAPY; ADULT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INTRACTABLE EPILEPSY; IRAN; LENNOX GASTAUT SYNDROME; LIVER TOXICITY; MALE; MIXED SEIZURE; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; NEPHROTOXICITY; TREATMENT OUTCOME; WEST SYNDROME;

EID: 76649137606     PISSN: 13010883     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Johnson MV. Seizure in childhood. In: Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics (18th ed). Philadelphia, Saunders 2007; p 2457.
2. Camfield PR, Camfield CS. Pediatric epilepsy . Swaiman KF, Ashwal S, Ferriero D M . Pediatric Neurology: principles & practice (4th ed). Philadelphia, Mosby Elsevier 2006: p 981.
3. Lee CY, Fu WM, Chen CC, et al. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 2008; 49: 888-897.
4. Piña-Garza JE, Levisohn P, Gucuyener K, et al. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months . Neurology 2008; 27; 70: 2099-2108.
5. Naritoku DK, Warnock CR, Messenheimer JA, et al Lamotrigine extended-release as adjunctive therapy for partial seizures . Neurology 2007; 69: 1610-1618.
6. Muñoz-Cabello B, Rufo-Campos M, Madruga-Garrido M, et al. Epileptic seizures in Angelman syndrome. Rev Neurol 2008; 47: 113-118.
7. Valencia I, Piñol-Ripoll G, Khurana DS, et al Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Eur J Paediatr Neurol 2009; 13: 141-145.
8. Mauri-Llerda JA, Morales-Martinez MD, Salas-Puig J, et al. A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. [The ERELMO study]. Rev Neurol 2008; 46: 197-202.
9. Bootsma HP, Vos AM, Hulsman J, et al. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center Epilepsy Behav 2008; 12: 262-268.
10. Kilaru S, Bergqvist AG . Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. Epilepsia 2007; 48: 1703-1707.
11. Barzagar M, Tonekaboni SH, Ghofrani M. Lamotrigine as add - on therapy in children with drug - resistant epilepsy (Iranian -experience). MJIRI 2003; 17: 15-18.
12. Jian L, Nagarajan L, de Klerk N, et al. Seizures in Rett syndrome: an overview from a one-year calendar study. Eur J Paediatr Neurol 2007; 11: 310-317.
13. Malphrus AD, Wilfong AA. Use of the newer antiepileptic drugs in pediatric epilepsies. Curr Treat Options Neurol 2007; 9: 256-267.
14. Trevathan E, Kerls SP, Hammer AE, et al. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Pediatrics 2006; 118: 371-378.
15. Hancock E, Cross H. Treatment of Lennox-Gastaut syndrome.Cochrane Database Syst Rev 2003; CD003277.
16. Wong M, Trevathan E. Infantile spasms. Pediatr Neurol 2001; 24: 89-98.
17. Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2001; CD001909.
18. French, JA, Kanner, AM, Bautista, J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1252-1260.
19. Chung AM, Eiland LS. Use of second - generation antiepileptic drugs in the pediatric population. Paediatr Drugs 2008; 10: 217-254.
20. Celebi A, Yalnmzoǧlu D, Turanli G, et al. Lamotrigine in children with refractory epilepsy.Turk J Pediatr 2008; 50: 426-431.
21. Gilad R, Sadeh M, Rapoport A, et al. Lamotrigine and catamenial epilepsy.Seizure 2008; 17: 531-534.
22. Chen SJ, Chang KP, Wong TT, et al. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study . Acta Paediatr Taiwan. 2006; 47: 123-126.
23. Zubcevic S, Cengic A, Catibusic F, et al. Use of lamotrigine in medically intractable epilepsies in children. Med Arh. 2008; 62: 162-164.
24. Knoester PD, Boendermaker AJ, Egberts AC, et al. Cost-effectiveness of add-on lamotrigine therapy in clinical practice .Epilepsy Res 2005; 67: 143-151.
25. Schmitz B, Bergmann L. The use of lamotrigine in female patients . Nervenarzt. 2007; 78: 912-922.
26. Wheless JW, Clarke DF, Arzimanoglou A, et al. Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007; 9: 353-412.
27. Biton V, Sackellares JC, Vuong A, et al. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005; 13; 65: 1737-1743.
28. Motte J , Trevathan E , Arvidsson JFV, et al. Lamotrigine for generalized seizures associated with the Lennox - Gastaut syndrome. N Engl J Med 1997; 337: 1807-1812 .
29. Timmings Pl , Richens A. Lamotrigine as add-on drug in the management of Lennox-Gastaut syndrome. Eur Neurol 1992; 32: 305-307.
30. Alvestad S, Lydersen S, Brodtkorb E. Cross-reactivity pattern of rash from current aromatic antiepileptic drugs. Epilepsy Res 2008; 80: 194-200.
31. Baumann RJ, Fakhoury TA, Kustra RP, et al. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy. Curr Med Res Opin 2007; 23: 2461-2465.